• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酵母分泌的体内生物素化重组抗体(生物抗体)在基于磁珠的酶联免疫吸附测定中的应用。

Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.

作者信息

Scholler Nathalie, Lowe Kimberly A, Bergan Lindsay A, Kampani Archana V, Ng Vivian, Forrest Robin M, Thorpe Jason D, Gross Jenny A, Garvik Barbara M, Drapkin Ronny, Anderson Garnet L, Urban Nicole

机构信息

School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 96104-6069, USA.

出版信息

Clin Cancer Res. 2008 May 1;14(9):2647-55. doi: 10.1158/1078-0432.CCR-07-1442.

DOI:10.1158/1078-0432.CCR-07-1442
PMID:18451228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2744596/
Abstract

PURPOSE

To measure circulating antigens, sandwich ELISA assays require two complementary affinity reagents. Mouse monoclonal antibodies (mAb) and polyclonal antibodies (pAb) are commonly used, but because their production is lengthy and costly, recombinant antibodies are emerging as an attractive alternative.

EXPERIMENTAL DESIGN

We developed a new class of recombinant antibodies called biobodies (Bb) and compared them to mAb for use in serodiagnosis. Bbs were secreted biotinylated in vivo by diploid yeast and used as affinity reagents after Ni purification. Bead-based assays for HE4 and mesothelin were developed using Bbs in combination with pAbs (Bb/pAb assays). To assess precision, reproducibility studies were done using four runs of 16 replicates at six analyte levels for each marker. Pearson correlations and receiver-operator characteristic analyses were done in 214 patient serum samples to directly compare the Bb/pAb assays to mAb assays. Diagnostic performance of the Bb/pAb assay was further assessed in an expanded set of 336 ovarian cancer cases and controls.

RESULTS

On average across analyte levels, Bb/pAb assays yielded within-run and between-run coefficients of variations of 11.7 and 23.8, respectively, for HE4 and 14.0 and 14.5, respectively, for mesothelin. In the subset (n = 214), Pearson correlations of 0.95 for HE4 and 0.92 for mesothelin were observed between mAb and Bb/pAb assays. The area under the curves for the mAb and Bb/pAb assays were not significantly different for HE4 (0.88 and 0.84, respectively; P = 0.20) or mesothelin (0.74 and 0.72, respectively; P = 0.38).

CONCLUSION

Yeast-secreted Bbs can be used reliably in cost-effective yet highly sensitive bead-based assays for use in large validation studies.

摘要

目的

为了检测循环抗原,夹心酶联免疫吸附测定(ELISA)需要两种互补的亲和试剂。小鼠单克隆抗体(mAb)和多克隆抗体(pAb)是常用的,但由于其生产过程漫长且成本高昂,重组抗体正成为一种有吸引力的替代选择。

实验设计

我们开发了一类名为生物抗体(Bb)的新型重组抗体,并将其与用于血清诊断的单克隆抗体进行比较。Bb由二倍体酵母在体内分泌生物素化,并在镍纯化后用作亲和试剂。使用Bb与多克隆抗体组合开发了基于磁珠的HE4和间皮素检测方法(Bb/pAb检测方法)。为了评估精密度,在每个标志物的六个分析物水平上进行了四次运行,每次运行16个重复的重复性研究。在214份患者血清样本中进行了Pearson相关性分析和受试者工作特征分析,以直接将Bb/pAb检测方法与单克隆抗体检测方法进行比较。在一组扩大的336例卵巢癌病例和对照中进一步评估了Bb/pAb检测方法的诊断性能。

结果

在分析物水平上平均而言,Bb/pAb检测方法对HE4的批内和批间变异系数分别为11.7和23.8,对间皮素分别为14.0和14.5。在子集(n = 214)中,单克隆抗体和Bb/pAb检测方法之间对HE4的Pearson相关性为0.95,对间皮素为0.92。单克隆抗体和Bb/pAb检测方法对HE4的曲线下面积无显著差异(分别为0.88和0.84;P = 0.20),对间皮素也无显著差异(分别为0.74和0.72;P = 0.38)。

结论

酵母分泌的Bb可可靠地用于经济高效且高度灵敏的基于磁珠的检测方法,用于大型验证研究。

相似文献

1
Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.酵母分泌的体内生物素化重组抗体(生物抗体)在基于磁珠的酶联免疫吸附测定中的应用。
Clin Cancer Res. 2008 May 1;14(9):2647-55. doi: 10.1158/1078-0432.CCR-07-1442.
2
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.通过酵母交配产生体内生物素化重组抗体的方法。
J Immunol Methods. 2006 Dec 20;317(1-2):132-43. doi: 10.1016/j.jim.2006.10.003. Epub 2006 Oct 30.
3
Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.卵巢癌风险状态对血清生物标志物间皮素、人附睾蛋白4(HE4)和癌抗原125(CA125)诊断性能的影响。
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1365-72. doi: 10.1158/1055-9965.EPI-08-1034.
4
Bead-based ELISA for validation of ovarian cancer early detection markers.基于微珠的酶联免疫吸附测定法用于验证卵巢癌早期检测标志物
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2117-24. doi: 10.1158/1078-0432.CCR-05-2007.
5
HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.人附睾蛋白4和间皮素:盆腔肿块患者卵巢癌的新型生物标志物。
Asian Pac J Cancer Prev. 2010;11(1):111-6.
6
Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.评估选定卵巢癌生物标志物的领先时间:一项巢式病例对照研究。
J Natl Cancer Inst. 2010 Jan 6;102(1):26-38. doi: 10.1093/jnci/djp438. Epub 2009 Dec 30.
7
Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.个人特征对卵巢癌高危绝经后健康女性血清CA125、间皮素和HE4水平的影响。
Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2480-7. doi: 10.1158/1055-9965.EPI-08-0150.
8
Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery.利用癌症特异性酵母分泌的体内生物素化重组抗体发现血清生物标志物。
J Transl Med. 2008 Jul 24;6:41. doi: 10.1186/1479-5876-6-41.
9
New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA.新型间皮素单克隆抗体,可用于免疫组织化学、荧光激活细胞分选、蛋白质免疫印迹法及酶联免疫吸附测定。
Clin Cancer Res. 2005 Aug 15;11(16):5840-6. doi: 10.1158/1078-0432.CCR-05-0578.
10
Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment.可预防CA125/间皮素依赖性细胞黏附的抗间皮素双特异性抗体的研发及体外验证
Cancer Lett. 2007 Oct 8;255(2):263-74. doi: 10.1016/j.canlet.2007.04.012. Epub 2007 Jun 7.

引用本文的文献

1
Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?靶向卵巢癌中的酪氨酸激酶:小分子抑制剂和单克隆抗体,我们目前进展如何?
Biomedicines. 2022 Aug 29;10(9):2113. doi: 10.3390/biomedicines10092113.
2
Integrating SpyCatcher/SpyTag covalent fusion technology into phage display workflows for rapid antibody discovery.将 SpyCatcher/SpyTag 共价融合技术整合到噬菌体展示工作流程中,用于快速抗体发现。
Sci Rep. 2019 Sep 6;9(1):12815. doi: 10.1038/s41598-019-49233-7.
3
Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy.上皮性卵巢癌患者肿瘤间皮素表达与血清间皮素的相关性:一种间皮素靶向治疗的潜在非侵入性生物标志物。
Mol Diagn Ther. 2017 Apr;21(2):187-198. doi: 10.1007/s40291-017-0255-2.
4
Human epididymis protein 4 expression positively correlated with miR-21 and served as a prognostic indicator in ovarian cancer.人附睾蛋白4的表达与miR-21呈正相关,并作为卵巢癌的一个预后指标。
Tumour Biol. 2016 Jun;37(6):8359-65. doi: 10.1007/s13277-015-4672-8. Epub 2016 Jan 5.
5
A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma.一种新型含分枝杆菌 Hsp70 的融合蛋白,靶向间皮素,增强抗肿瘤免疫并延长卵巢癌和间皮瘤小鼠模型的存活时间。
J Hematol Oncol. 2014 Feb 24;7:15. doi: 10.1186/1756-8722-7-15.
6
HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.HE4 转录和剪接变体在子宫内膜癌中的特异性表达及其与患者生存的相关性。
Int J Mol Sci. 2013 Nov 18;14(11):22655-77. doi: 10.3390/ijms141122655.
7
HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines.HE4 (WFDC2) 促进子宫内膜癌细胞系的肿瘤生长。
Int J Mol Sci. 2013 Mar 15;14(3):6026-43. doi: 10.3390/ijms14036026.
8
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125.评估卵巢癌缓解标志物 HE4、MMP7 和间皮素,并与既定标志物 CA125 进行比较。
Gynecol Oncol. 2012 Apr;125(1):65-9. doi: 10.1016/j.ygyno.2011.11.050. Epub 2011 Dec 7.
9
Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.血清 HE4 与子宫内膜癌肿瘤大小和肌层浸润的相关性。
Gynecol Oncol. 2012 Feb;124(2):270-5. doi: 10.1016/j.ygyno.2011.10.025. Epub 2011 Oct 28.
10
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.两种用于诊断卵巢癌的新型生物标志物,间皮素和人附睾蛋白4 。
Expert Opin Med Diagn. 2011 May 1;5(3):227-240. doi: 10.1517/17530059.2011.559459.

本文引用的文献

1
Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment.可预防CA125/间皮素依赖性细胞黏附的抗间皮素双特异性抗体的研发及体外验证
Cancer Lett. 2007 Oct 8;255(2):263-74. doi: 10.1016/j.canlet.2007.04.012. Epub 2007 Jun 7.
2
Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.BRCA的启示:输卵管伞端成为盆腔浆液性癌的起源部位。
Clin Med Res. 2007 Mar;5(1):35-44. doi: 10.3121/cmr.2007.702.
3
Changes in cancer worry associated with participation in ovarian cancer screening.与参与卵巢癌筛查相关的癌症担忧变化。
Psychooncology. 2007 Sep;16(9):814-20. doi: 10.1002/pon.1151.
4
Comparing adaptive and non-adaptive algorithms for cancer early detection with novel biomarkers.比较用于癌症早期检测的适应性和非适应性算法与新型生物标志物。
Cancer Biomark. 2006;2(3-4):151-62. doi: 10.3233/cbm-2006-23-407.
5
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.通过酵母交配产生体内生物素化重组抗体的方法。
J Immunol Methods. 2006 Dec 20;317(1-2):132-43. doi: 10.1016/j.jim.2006.10.003. Epub 2006 Oct 30.
6
Mesothelin variant 1 is released from tumor cells as a diagnostic marker.间皮素变体1作为一种诊断标志物从肿瘤细胞中释放出来。
Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1014-20. doi: 10.1158/1055-9965.EPI-05-0334.
7
Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.开发一种CA125-间皮素细胞黏附测定法作为生物制剂发现的筛选工具。
Cancer Lett. 2007 Mar 8;247(1):130-6. doi: 10.1016/j.canlet.2006.03.029. Epub 2006 May 4.
8
Bead-based ELISA for validation of ovarian cancer early detection markers.基于微珠的酶联免疫吸附测定法用于验证卵巢癌早期检测标志物
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2117-24. doi: 10.1158/1078-0432.CCR-05-2007.
9
Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.血清间皮素的检测与定量,间皮素是一种用于间皮瘤和卵巢癌患者的肿瘤标志物。
Clin Cancer Res. 2006 Jan 15;12(2):447-53. doi: 10.1158/1078-0432.CCR-05-1477.
10
New tumor markers: CA125 and beyond.新型肿瘤标志物:CA125及其他。
Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:274-81. doi: 10.1111/j.1525-1438.2005.00441.x.